Lensar Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Lensar Inc 's inventory turnover ratio sequentially decreased to 1.38 in the second quarter 2026, unsurprisingly, as the Lensar Inc markets continue to deteriorate, and LNSR's faces growing challenges to bring down its inventories. Lensar Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 264 days, from 247 days, in the Mar 31 2026 quarter.

Within Healthcare sector 275 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1582 in the first quarter 2026, to 1718.

LNSR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lensar Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LNSR Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	29.25 %	50.74 %	88.31 %	38.3 %	7.3 %
Y / Y Cost of Sales Growth	-2.78 %	0.17 %	-5.56 %	13.85 %	18.68 %
Inventory Turnover Ratio (TTM)	1.38	1.48	1.63	1.91	2.03
LNSR's Total Ranking	# 1718	# 1582	# 994	# 1168	#
Average inventory processing period	264	246	223	191	180
Seq. Inventory Growth	7.67 %	7.34 %	4.49 %	7.03 %	25.57 %
Seq. Cost of Sales Growth	-4.64 %	-22.47 %	9.76 %	19.81 %	-1.75 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 126
Healthcare Sector	# 276
Overall Market	# 1718

Inventory Turnover Ratio Statistics
High	Average	Low
2.84	1.62	1.02
(Sep 30 2022)		(Jun 30 2021)

LNSR Company Profile >> Back to LNSR Efficiency Comparisons >> Compare LNSR Inventory Turnover Ratio to its Competitors

Financial Statements
Lensar Inc 's Inventories	$ 25 Millions	Visit LNSR's Balance sheet
Lensar Inc 's Cost of Revenues TTM	$ 31 Millions	Visit LNSR's Income Statement
What are LNSR's Sales?		Visit LNSR's Sales by Segment

Other Inventory Turnover Ratios
Lensar Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LNSR's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LNSR's Competitors
Inventory Turnover Ratio for LNSR's Suppliers
Inventory Turnover Ratio for LNSR's Customers

You may also want to know
LNSR's Sales Growth Rates	LNSR's Pe Price to earnings ratio	LNSR's Receivables Turnover Ratio	LNSR's Stock Quote
LNSR's Net Income Growth Rates	LNSR's Ps Price to Sales ratio	LNSR's Sales per Employee	LNSR's Asset Turnover Ratio
LNSR's Net Margin	LNSR's Pb Price to Book ratio	LNSR's Financial Strength Ratios	LNSR's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Mirum Pharmaceuticals Inc	3.40	$ 85.221 Millions	$ 25 Millions
Zai Lab Limited	3.39	$ 195.542 Millions	$ 58 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
Evolus Inc	3.37	$ 105.904 Millions	$ 31 Millions
Gilead Sciences Inc	3.35	$ 6,217.000 Millions	$ 1,857 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Exelixis Inc	3.28	$ 85.665 Millions	$ 26 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Solventum Corporation	3.22	$ 3,421.000 Millions	$ 1,061 Millions
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Zevra Therapeutics Inc	3.14	$ 6.180 Millions	$ 2 Millions
Prestige Consumer Healthcare Inc	3.13	$ 513.522 Millions	$ 164 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions
Becton Dickinson And Company	3.09	$ 11,161.000 Millions	$ 3,615 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Revvity Inc	2.98	$ 1,136.473 Millions	$ 381 Millions
Amneal Pharmaceuticals Inc	2.98	$ 1,891.689 Millions	$ 635 Millions
Akebia Therapeutics Inc	2.96	$ 44.632 Millions	$ 15 Millions
Msa Safety Inc	2.92	$ 1,021.036 Millions	$ 350 Millions
Ligand Pharmaceuticals Incorporated	2.91	$ 32.387 Millions	$ 11 Millions
Logicmark Inc	2.83	$ 3.881 Millions	$ 1 Millions
Iovance Biotherapeutics inc	2.81	$ 152.872 Millions	$ 54 Millions
Livanova Plc	2.79	$ 468.065 Millions	$ 168 Millions
Merck and Co Inc	2.79	$ 17,996.000 Millions	$ 6,447 Millions
Inspiremd Inc	2.78	$ 8.847 Millions	$ 3 Millions
Dentsply Sirona Inc	2.77	$ 1,839.000 Millions	$ 663 Millions
Ani Pharmaceuticals Inc	2.69	$ 387.398 Millions	$ 144 Millions

Date modified: 2026-09-03T11:57:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.